Role of immunocompetent cells in nonimmune renal diseases

Rocklin, 1970, In vitro evidence for cellular hypersensibility to glomerular basement-membrane antigens in human glomerulonephritis, N Engl J Med, 283, 497, 10.1056/NEJM197009032831001 Dixon, 1970, What are sensitized cells doing in glomerulonephritis?, N Engl J Med, 283, 536, 10.1056/NEJM197009032831011 Strutz, 1994, The role of lymphocytes in the progression of interstitial disease, Kidney Int, 45, S106 Schena, 1997, Progression of renal damage in human glomerulonephritides: Is there a sleight of hand in winning the game?, Kidney Int, 52, 1439, 10.1038/ki.1997.475 Müller, 1996, Prevention of progression of renal fibrosis: How far are we?, Kidney Int, 49, S75 Risdon, 1968, Relationship between renal function and histologic changes found in renal biopsy specimens from patients with persistent glomerulonephritis, Lancet, 2, 363, 10.1016/S0140-6736(68)90589-8 Schainuck, 1970, Structural-functional correlations in renal disease. II. The correlations, Hum Pathol, 1, 631, 10.1016/S0046-8177(70)80061-2 Strutz, 1995, On the progression of chronic renal disease, Nephron, 69, 371, 10.1159/000188505 Bohle, 1997, Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies and chronic interstitial nephritides, Kidney Int, 49, S2 Nath, 1992, Tubulointerstitial changes as a major determinant in the progression of renal damage, Am J Kidney Dis, 20, 1, 10.1016/S0272-6386(12)80312-X Main, 1992, T cells and macrophages and their role in renal injury, Semin Nephrol, 12, 395 Lan, 1997, The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat, J Exp Med, 185, 1455, 10.1084/jem.185.8.1455 Miyazaki, 1997, Up-regulation of macrophage colony-stimulating factor (M-CSF) and migration inhibitory factor (MIF) expression and monocyte recruitment during lipid-induced glomerular injury in the exogenous hypercholesterolaemic (ExHC) rat, Clin Exp Immunol, 108, 318, 10.1046/j.1365-2249.1997.3671260.x Neilson, 1989, Pathogenesis and therapy of interstitial nephritis, Kidney Int, 35, 1257, 10.1038/ki.1989.118 Yee, 1991, Tubulointerstitial injury following glomerulonephritis, Semin Nephrol, 11, 361 Goes, 1995, Ischemic acute tubular necrosis induces and extensive local cytokine response, Transplantation, 59, 565, 10.1097/00007890-199502270-00022 Truong, 1992, Experimental chronic renal ischemia: Morphologic and immunologic studies, Kidney Int, 41, 1676, 10.1038/ki.1992.241 Mampaso, 1983, Characterization of inflammatory cells in autoimmune tubulointerstitial nephritis in rats, Kidney Int, 23, 448, 10.1038/ki.1983.41 Eddy, 1989, Interstitial nephritis induced by protein overload proteinuria, Am J Pathol, 135, 719 Eddy, 1988, Acute tubulointerstitial nephritis associated by aminonucleoside nephrosis, Kidney Int, 33, 14, 10.1038/ki.1988.3 Gillum, 1990, Characterization of the interstitial cellular infiltrate in experimental chronic cyclosporine nephropathy, Transplantation, 49, 793, 10.1097/00007890-199004000-00027 Lippman, 1948, Mechanism of proteinuria: Effect of parenteral bovine albumin injections on hemoglobin excretion in rats, Am J Physiol, 154, 532, 10.1152/ajplegacy.1948.154.3.532 Terry, 1948, Proteinuria related to hyperproteinemia in dogs following plasma given parenterally: A renal threshold for plasma proteins, J Exp Med, 87, 561, 10.1084/jem.87.6.561 Eddy, 1995, Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein overload proteinuria, Kidney Int, 47, 1546, 10.1038/ki.1995.218 Kees-Folts, 1994, Tubular catabolism of albumin is associated with the release of an inflammatory lipid, Kidney Int, 45, 1697, 10.1038/ki.1994.222 Anderson, 1962, Fine structural alterations in the rat following intraperitoneal bovine albumin, Am J Pathol, 40, 555 Andrews, 1977, A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss, Lab Invest, 36, 183 Camussi, 1982, In vitro alternative pathway activation of complement by the brush border of proximal tubules of normal rat kidney, J Immunol, 128, 1659, 10.4049/jimmunol.128.4.1659 Wellmann, 1971, Renal changes in experimental hypercholesterolemia in normal and subdiabetic rabbits. II. Long-term studies, Lab Invest, 24, 144 Moorhead, 1982, Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease, Lancet, 2, 1309, 10.1016/S0140-6736(82)91513-6 Gröne, 1989, Induction of glomerulosclerosis by dietary lipids: A functional and morphologic study in the rat, Lab Invest, 60, 433 Kasiske, 1990, Renal injury of diet-induced hypercholestemia in rats, Kidney Int, 37, 880, 10.1038/ki.1990.62 Diamond, 1990, Cholestyramine resin ameliorates chronic aminonucleoside nephrosis, Am J Clin Nutr, 51, 606, 10.1093/ajcn/51.4.606 Diamond, 1992, A putative role of hypercholesterolemia in progressive glomerular injury, Annu Rev Med, 43, 83, 10.1146/annurev.me.43.020192.000503 Keane, 1991, Hyperlipemia and progressive renal disease, Kidney Int, 39, S41 Diamond, 1991, Effect of lipid abnormalities on the progression of renal damage: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis, Kidney Int, 39, S29 Magil, 1989, Monocytes and focal glomerulosclerosis, Lab Invest, 61, 404 Schönholzer, 1992, Intraglomerular foam cells and human focal glomerulosclerosis, Nephron, 62, 130, 10.1159/000187020 Keane, 1994, Lipids and the kidney, Kidney Int, 46, 910, 10.1038/ki.1994.349 Eddy, 1996, Interstitial inflammation and fibrosis in rats with diet induced hypercholesterolemia, Kidney Int, 50, 1139, 10.1038/ki.1996.421 Heptinstall, 1992, Pyelonephritis: Pathologic features, 1540 Ross, 1999, Atherosclerosis: An inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207 Hostetter, 1981, Hyperfiltration of remnant nephrons: A potentially adverse response to renal ablation, Am J Physiol, 241, F85 Shimamura, 1975, A progressive glomerulosclerosis occurring in partial five-sixth nephrectomy, Am J Pathol, 79, 95101 Zatz, 1996, Haemodynamically mediated glomerular injury: The end of a 15-year-old controversy?, Curr Opin Nephrol Hypertens, 5, 468, 10.1097/00041552-199611000-00002 Floege, 1992, Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model, Kidney Int, 41, 297, 10.1038/ki.1992.42 Wolf, 1993, Angiotensin II induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta, J Clin Invest, 92, 1366, 10.1172/JCI116710 Kagami, 1994, Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells, J Clin Invest, 93, 2431, 10.1172/JCI117251 Wu, 1997, Transforming growth factor β1 and the renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system, Kidney Int, 51, 1553, 10.1038/ki.1997.214 Hostetter, 1986, Chronic effects of dietary protein in the rat with intact and reduced renal mass, Kidney Int, 30, 509, 10.1038/ki.1986.215 Correa-Rotter, 1992, Effect of dietary protein on renin and angiotensinogen gene expression after renal ablation, Am J Physiol, 262, F631 Yang, 1998, Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney, Nephrol Dial Transplant, 13, 1967, 10.1093/ndt/13.8.1967 Fuhihara, 1998, Mycophenolate mofetil attenuates renal injury in the rat remnant kidney, Kidney Int, 54, 1510, 10.1046/j.1523-1755.1998.00138.x Romero, 1999, Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats, Kidney Int, 55, 945, 10.1046/j.1523-1755.1999.055003945.x Schiller, 1997, Focal glomerulosclerosis in the remnant kidney model—An inflammatory disease mediated by cytokines, Nephrol Dial Transplant, 12, 430, 10.1093/ndt/12.3.430 Wu, 1997, Macrophage and myofibroblast proliferation in remnant kidney. Role of angiotensin II, Kidney Int, 52, S221 Remuzzi, 1999, Combining an antiproteinuric approach with mycophenolate mofetil suppresses progressive nephropathy of experimental animals, J Am Soc Nephrol, 10, 1542, 10.1681/ASN.V1071542 Nagle, 1971, Unilateral obstructive uropathy in the rabbit. I. Early morphologic, physiologic and histochemical changes, Lab Invest, 28, 456 Nagle, 1976, Proliferation of renal interstitial cells following injury induced by ureteral obstruction, Lab Invest, 35, 18 Okegawa, 1983, Metabolic and cellular alterations underlying the exaggerated renal prostaglandin and thromboxane synthesis in ureter obstruction in rabbits, J Clin Invest, 71, 61, 10.1172/JCI110754 Lefkowitz, 1984, Macrophage-dependent arachidonate metabolism in hydronephrosis, Kidney Int, 26, 10, 10.1038/ki.1984.127 Klahr, 1983, Pathophysiology of obstructive nephropathy, Kidney Int, 23, 414, 10.1038/ki.1983.36 Schreiner, 1988, Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney, Kidney Int, 34, 487, 10.1038/ki.1988.207 Halushka, 1981, Thromboxane A2 and prostacyclin production by lipopolysaccharide-stimulated peritoneal macrophages, J Reticulonedothel Soc, 30, 445 Kaneto, 1993, Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation, Kidney Int, 44, 313, 10.1038/ki.1993.246 Mandell, 1983, Congenital polycystic kidney disease, Am J Pathol, 113, 112 Takahashi, 1991, A hereditary model of slowly progressive polycystic kidney disease in the mouse, J Am Soc Nephrol, 1, 980, 10.1681/ASN.V17980 Nakamura, 1993, Growth factor gene expression in kidney of murine polycystic kidney disease, J Am Soc Nephrol, 3, 1378, 10.1681/ASN.V371378 Kagaoka, 1990, Upregulation of platelet-derived growth factor A and B gene expression in alveolar macrophages in individuals with idiopathic pulmonary fibrosis, J Clin Invest, 85, 2023, 10.1172/JCI114669 Nakamura, 1992, Activated peripheral blood mononuclear cells in IgA nephropathy express platelet-derived growth factor, J Lab Clin Med, 120, 212 Kagaoka, 1990, Regulation of insulin-like growth factor I gene expression in the human macrophage-like cell line U937, J Clin Invest, 85, 448, 10.1172/JCI114458 Eddy, 1996, Molecular insights into renal interstitial fibrosis, J Am Soc Nephrol, 7, 2495, 10.1681/ASN.V7122495 Wolf, 1999, Molecular mechanisms of diabetic renal hypertrophy, Kidney Int, 56, 393, 10.1046/j.1523-1755.1999.00590.x Kimmelstiel, 1936, Intercapillary lesions in glomeruli of the kidney, Am J Pathol, 12, 83 Ziyadeh, 1991, The renal tubulointerstitium in diabetes mellitus, Kidney Int, 39, 464, 10.1038/ki.1991.57 Mauer, 1984, Structural-functional relationships in diabetic nephropathy, J Clin Invest, 74, 1143, 10.1172/JCI111523 Lane, 1993, Renal interstitial expansion in insulin-dependent diabetes mellitus, Kidney Int, 43, 661, 10.1038/ki.1993.95 Hooke, 1987, Leukocyte analysis using monoclonal antibodies in human glomerulonephritis, Kidney Int, 31, 964, 10.1038/ki.1987.93 Cohen, 1996, Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy, J Am Soc Nephrol, 7, 183, 10.1681/ASN.V72183 Lindeman, 1990, Overview: Renal physiology and pathophysiology of aging, Am J Kidney Dis, 4, 275, 10.1016/S0272-6386(12)80002-3 Baylis, 1998, The aging kidney: Insights from experimental studies, J Am Soc Nephrol, 9, 699, 10.1681/ASN.V94699 Epstein, 1996, Aging and the kidney, J Am Soc Nephrol, 7, 1106, 10.1681/ASN.V781106 Couser, 1975, Mesangial lesion and focal glomerulosclerosis in the aging rat, Lab Invest, 33, 493 Goldstein, 1988, Age-related nephropathy in laboratory rats, FASEB J, 2, 2241, 10.1096/fasebj.2.7.3280378 Abrass, 1995, Aging-associated change in extracellular matrix, Am J Pathol, 146, 742 Thomas, 1998, Tubulointerstitial disease in aging: Evidence for underlying peritubular capillary damage, a potential role for renal ischemia, J Am Soc Nephrol, 9, 231, 10.1681/ASN.V92231 Ruiz-Torres, 1998, Age-related increase in expression of TGF-β1 in the rat kidney: Relation to morphologic changes, J Am Soc Nephrol, 9, 782, 10.1681/ASN.V95782 Hewitson, 1998, Evolution of tubulointerstitial fibrosis in experimental renal infection and scarring, J Am Soc Nephrol, 9, 632, 10.1681/ASN.V94632 Miller, 1976, Experimental pyelonephritis: The effect of chronic active pyelonephrhitis on renal function, Kidney Int, 9, 23, 10.1038/ki.1976.3 Tamaki, 1996, Transforming growth factor-β1 in hypertensive renal injury in Dahl salt-sensitive rats, J Am Soc Nephrol, 7, 2578, 10.1681/ASN.V7122578 Johnson, 2000, Tubulointerstitial injury and loss of nitric oxide synthases parallel the development of hypertension in the Dahl-S rat, J Hypertens, 18, 1497, 10.1097/00004872-200018100-00019 Abumiya, 1966, Heterogeneity in the appearance and distribution of macrophage subsets and their possible involvement in hypertensive vascular lesions in rats, Lab Invest, 75, 125 Geiger, 1997, Effects of early and late antihypertensive treatment on extracellular matrix proteins and mononuclear cells in uninephrectomized SHR, Kidney Int, 51, 750, 10.1038/ki.1997.106 Johnson, 1999, Renal injury and salt-sensitive hypertension after exposure to catecholamines, Hypertension, 34, 151, 10.1161/01.HYP.34.1.151 Lombardi, 1999, Salt-sensitive hypertension develops after short-term exposure to angiotensin II, Hypertension, 33, 1013, 10.1161/01.HYP.33.4.1013 Mai, 1993, Early interstitial changes in hypertension-induced renal injury, Hypertension, 22, 754, 10.1161/01.HYP.22.5.754 Eng, 1994, Renal proliferation and phenotypic changes in rats with two-kidneys one-clip Goldblatt hypertension, Am J Hypertens, 7, 177, 10.1093/ajh/7.2.177 Oliveira-Ribeiro, 1992, Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension, Hypertension, 20, 298303 Jover, 1993, Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade, Hypertension, 21, 944, 10.1161/01.HYP.21.6.944 Pollock, 1993, Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition, Hypertension, 21, 660, 10.1161/01.HYP.21.5.660 Melaragno, 1996, Role of angiotensin II in hypertension produced by chronic inhibition of nitric oxide synthase in conscious rats, Am J Physiol, 271, H806 Cunha, 1993, Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats, Am J Hypertens, 6, 806, 10.1093/ajh/6.9.806 Verhagen, 1998, Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition, J Am Soc Nephrol, 9, 755, 10.1681/ASN.V95755 De Caterina, 1995, Nitric oxide decreases cytokine induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines, J Clin Invest, 96, 60, 10.1172/JCI118074 Spiecker, 1998, Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants, J Leukoc Biol, 63, 732, 10.1002/jlb.63.6.732 Lefer, 1996, The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion, Cardiovasc Res, 32, 743, 10.1016/S0008-6363(96)00073-9 Verstrepen, 1995, Time course of growth factor expression in mercuric chloride acute renal failure, Nephrol Dial Transplant, 10, 1361 NAVA M, R OMERO F, Q UIROZ Y, et al: Melatonin attenuates the acute renal failure and the oxidative stress induced by mercuric chloride in rats. Am J Physiol (Renal) F910-F918, 2000 Glassock, 1977, Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis, Lab Invest, 36, 519 Harris, 1990, Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after the administration of aminonucleoside of puromycin, J Clin Invest, 86, 1115, 10.1172/JCI114816 Jones, 1991, Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis, Kidney Int, 40, 1020, 10.1038/ki.1991.310 Magil, 1996, Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant, J Am Soc Nephrol, 7, 2340, 10.1681/ASN.V7112340 Diamond, 1989, Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury, Am J Physiol, 257, F798 Diamond, 1991, Sublethal X-irradiation during the acute puromycin nephrosis prevents the late renal injury: Role of macrophages, Am J Physiol, 260, F779 Diamond, 1992, The role of reactive oxygen species in animal models of glomerular disease, Am J Kidney Dis, 19, 292, 10.1016/S0272-6386(13)80013-3 Shihab, 1996, Role of transforming growth factor-β1 in experimental chronic cyclosporine nephropathy, Kidney Int, 49, 1141, 10.1038/ki.1996.165 Shihab, 1997, Mechanism of fibrosis in experimental tracolimus nephrotoxicity, Transplantation, 64, 1829, 10.1097/00007890-199712270-00034 Pichler, 1995, Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin, J Am Soc Nephrol, 6, 1186, 10.1681/ASN.V641186 Elzinga, 1993, Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: Role of sodium intake, J Am Soc Nephrol, 4, 214, 10.1681/ASN.V42214 Bennett, 1994, Nephrotoxicity of immunosuppressive drugs, Nephrol Dial Transplant, 9, 141 Segerer, 2000, Chemokines, chemokine receptors and renal disease: From basic science to pathophysiologic and therapeutic studies, J Am Soc Nephrol, 11, 152, 10.1681/ASN.V111152 Brady, 1994, Leukocyte adhesion molecules and kidney diseases, Kidney Int, 45, 1285, 10.1038/ki.1994.169 Hill, 1994, ICAM-1 directs migration and localization of interstitial leukocytes in experimental glomerulonephritis, Kidney Int, 45, 32, 10.1038/ki.1994.4 Tang, 1994, Cytokine expression, upregulation of intracellular adhesion molecule-1 and leukocyte infiltration in tubulointerstitial nephritis, Lab Invest, 70, 631 Matsusaka, 1996, Angiotensin in progressive renal diseases: Theory and practice, J Am Soc Nephrol, 7, 2025, 10.1681/ASN.V7102025 Fogo, 2000, The role of plasminogen II and plasma plasminogen activator inhibitor-1 in progressive glomerulonephritis, Am J Kidney Dis, 36, 179, 10.1016/S0272-6386(00)70324-6 Fine, 1998, Progressive renal disease: The chronic hypoxia hypothesis, Kidney Int, 53, S74 Fine, 2000, Is there a mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia, Kidney Int, 57, S22, 10.1046/j.1523-1755.2000.07512.x Laurent, 1986, Reactive oxygen species: Production and role in the kidney, Am J Physiol, 251, F765 Blantz, 1976, Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat, J Clin Invest, 57, 419, 10.1172/JCI108293 Bohrer, 1977, Mechanism of angiotensin-induced proteinuria in the rat, Am J Physiol, 233, F13 Anderson, 1986, Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension, J Clin Invest, 77, 1993, 10.1172/JCI112528 Zatz, 1986, Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension, J Clin Invest, 77, 1925, 10.1172/JCI112521 Largo, 1999, Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria, Hypertension, 33, 732, 10.1161/01.HYP.33.2.732 Kim, 1996, Angiotensin II increases monocyte binding to endothelial cells, Biochem Byophys Res Commun, 226, 862, 10.1006/bbrc.1996.1441 Gräfe, 1997, Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin, Circ Res, 81, 804, 10.1161/01.RES.81.5.804 Krejcy, 1996, Influence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo, Can J Physiol Pharmacol, 74, 9, 10.1139/y95-218 Ruiz-Ortega, 1998, Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis, J Immunol, 161, 430, 10.4049/jimmunol.161.1.430 Johnson, 1992, Renal injury from angiotensin II-mediated hypertension, Hypertension, 19, 464, 10.1161/01.HYP.19.5.464 Goetzl, 1980, The preferential human mononuclear leukocyte chemotactic activity of the substituent tetrapeptides of angiotensin II, Biochem Biophys Res Commun, 97, 1097, 10.1016/0006-291X(80)91488-6 Hahn, 1994, Activation of human peripheral monocytes by angiotensin II, FEBS Lett, 347, 178, 10.1016/0014-5793(94)00531-1 Furukawa, 1996, Angiotensin II receptor antagonist reduces graft coronary artery disease and preserves graft status in a murine model, Circulation, 93, 333, 10.1161/01.CIR.93.2.333 Tanaka, 1994, An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis, Circulation, 90, 2051, 10.1161/01.CIR.90.4.2051 Amuchastegui, 1998, Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism, J Am Soc Nephrol, 9, 1948, 10.1681/ASN.V9101948 Benedikrsson, 1996, Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure, Transplantation, 62, 1634, 10.1097/00007890-199612150-00018 Shimada, 1978, Binding site for angiotensin II in human mononuclear leukocytes, J Biochem, 84, 1013, 10.1093/oxfordjournals.jbchem.a132183 Nataraj, 1999, Angiotensin regulates cellular immune responses through a calcineurin-dependent pathway, J Clin Invest, 104, 1693, 10.1172/JCI7451 Keldar, 1994, Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: A possible role for angiotensin II, Atherosclerosis, 107, 71, 10.1016/0021-9150(94)90143-0 Boyce, 1989, Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis, Kidney Int, 35, 778, 10.1038/ki.1989.52 Stratta, 1989, Mesangiolysis and endothelial lesions due to peroxidative damage in the rabbit, Nephron, 51, 250, 10.1159/000185294 Yoshioka, 1991, Reactive oxygen metabolites cause massive, reversible proteinuria and a glomerular sieving defect without apparent ultrastructural abnormality, J Am Soc Nephrol, 2, 902, 10.1681/ASN.V24902 Johnson, 1987, New mechanism of glomerular injury: Myeloperoxidase-hydrogen peroxide-halide system, J Clin Invest, 79, 1379, 10.1172/JCI112965 Johnson, 1988, Morphological correlates of glomerular oxidant injury induced by the myeloperoxidase-hydrogen peroxide-halide system of he neutrophil, Lab Invest, 58, 294 Satriano, 1993, Oxygen radicals as second messengers for expression of monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin G, J Clin Invest, 92, 1564, 10.1172/JCI116737 Satriano, 1997, Regulation of RANTES and ICAM expression in mesangial cells, J Am Soc Nephrol, 8, 596, 10.1681/ASN.V84596 Schreck, 1991, A role for oxygen radicals as second messengers, Trend Cell Biol, 1, 39, 10.1016/0962-8924(91)90072-H Schlöndorff, 1995, The role of chemokines in the initiation and progression of renal disease, Kidney Int, 47, S44 Quinn, 1987, Oxidatively modified low-density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis, Proc Soc Natl Acad Sci USA, 84, 2995, 10.1073/pnas.84.9.2995 Witzum, 1991, Role of oxidized low-density lipoproteins in atherosclerosis, J Clin Invest, 88, 1785, 10.1172/JCI115499 Kume, 1992, Lisophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocytes in cultured human and rabbit arterial endothelial cells, J Clin Invest, 90, 1138, 10.1172/JCI115932 Khan, 1995, Modified low-density lipoproteins and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells, J Clin Invest, 95, 1262, 10.1172/JCI117776 Modi, 1990, Effects of probucol on renal function in rats with bilateral ureteral obstruction, Kidney Int, 38, 843, 10.1038/ki.1990.280 Modi, 1992, Effect of probucol in the renal function and structure in rats with subtotal kidney ablation, J Lab Clin Med, 120, 310 Yoshimura, 1999, Effect of simvastatin of proliferative nephritis and cell-cycle protein expression, Kidney Int, 56, S84, 10.1046/j.1523-1755.1999.07121.x Nishimura, 1999, Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation, Kidney Int, 56, S97, 10.1046/j.1523-1755.1999.07124.x Galle, 1999, Atherogenic lipoproteins, oxidative stress and cell death, Kidney Int, 56, S62, 10.1046/j.1523-1755.1999.07116.x Rook, 1998, Immunity to bacteria and fungi, 239 Heng, 1994, Heat-shock protein 65 and activated gamma/delta T cells in injured arteries, Lancet, 2, 921, 10.1016/S0140-6736(94)92271-3 Fu, 1993, In vivo response of murine gamma delta T cells to heat shock protein-derived peptide, Proc Natl Acad Sci USA, 90, 322, 10.1073/pnas.90.1.322 Haas, 1993, Gamma/delta cells, Annu Rev Immunol, 11, 637, 10.1146/annurev.iy.11.040193.003225 Rajagopalan, 1990, Pathogenetic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: Isolation of CD4-T helper cell lines that express gamma delta T-cell antigen receptors, Proc Natl Acad Sci USA, 87, 7020, 10.1073/pnas.87.18.7020 Hohlfeld, 1992, The role of gamma-delta T lymphocytes in inflammatory muscle disease, Chem Imunol, 53, 75 Falk, 1995, Infiltration of the kidney by alpha beta and gamma delta T cells: Effect on progression of IgA nephropathy, Kidney Int, 47, 177, 10.1038/ki.1995.21 Abrignani, 1998, Antigen-independent activation of resting T cells in the liver of patients with chronic hepatitis, Dev Biol Stand, 92, 191 Unutmaz, 1994, Antigen-independent activation of naive and memory resting T cells by a cytokine combination, J Exp Med, 180, 1159, 10.1084/jem.180.3.1159 Unutmaz, 1995, Human naïve T cells activated by cytokine differentiate into split phenotype with functional features intermediate between naïve and memory T cells, Int Immunol, 7, 1417, 10.1093/intimm/7.9.1417 Bacon, 1995, Activation of dual T cell signaling pathways by the chemokine RANTES, Science, 269, 1727, 10.1126/science.7569902 Fukui, 1997, IL-7 induces proliferation, variable cytokine-producing ability and IL-2 responsiveness in naïve CD4+ T cells from human cord blood, Immunol Lett, 59, 21, 10.1016/S0165-2478(97)00093-X Siefken, 1997, CD28-mediated activation of resting human T cells without costimulation of the CD3/TCR complex, Cell Immunol, 176, 59, 10.1006/cimm.1996.1066 Perrin, 1999, Differential requirements of naïve and memory T cells for CD28 costimulation in autoimmune pathogenesis, Histol Histopathol, 14, 1269 Sturmhofel, 1995, Antigen-independent, integrin-mediated T cell activation, J Immunol, 154, 2104, 10.4049/jimmunol.154.5.2104 Saito, 1990, Contribution of mononuclear leukocytes to the progression of experimental focal glomerular sclerosis, Kidney Int, 37, 1076, 10.1038/ki.1990.88 Sollinger, 1995, Mycophenolate mofetil, Kidney Int, 48, S14 Hauser, 1995, Effect of mycophenolic acid on TNF alpha-induced expression of adhesion molecules in human endothelial cells in vitro, Br J Pharmacol, 122, 1315, 10.1038/sj.bjp.0701517 Remuzzi, 1994, Dissociation between anti-proteinuric and anti-hypertensive effects of angiotensin-converting enzyme inhibition in rats, Am J Physiol, 267, F1034 Kliem, 1996, Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats, Kidney Int, 49, 666, 10.1038/ki.1996.95 Bhagat, 1999, Effects of cytokines on nitric oxide pathways in human vasculature, Curr Opin Nephrol Hypertens, 8, 89, 10.1097/00041552-199901000-00014 Romero, 2000, Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in rabbits, Atherosclerosis, 152, 127, 10.1016/S0021-9150(99)00458-X Emeson, 1993, Accelerated atherosclerosis in hyperlipidemic C57BL mice treated with cyclosporin A, Am J Pathol, 142, 1906 Roselaar, 1995, Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity, J Clin Invest, 96, 1389, 10.1172/JCI118174 Matsumoto, 1998, Influence of FK506 on the experimental atherosclerosis in cholesterol-fed rabbits, Atherosclerosis, 139, 95, 10.1016/S0021-9150(98)00066-5 Drew, 1995, Cyclosporin treatment reduces early atherosclerosis in the cholesterol-fed rabbits, Atherosclerosis, 116, 181, 10.1016/0021-9150(95)05539-9 Fujihara, 1992, Glomerular abnormalities in long-term experimental diabetes: Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy, Diabetes, 41, 286, 10.2337/diab.41.3.286 Tapia, 1990, Determinants of renal damage in rats with systemic hypertension, Kidney Int, 38, 642, 10.1038/ki.1990.254 Simons, 1993, Pathogenesis of glomerular injury in the fawn-hooded rat: Early glomerular hypertension predicts glomerular sclerosis, Am J Nephrol, 3, 1775, 10.1681/ASN.V3111775 Schmitz, 1992, Renal injury in obese Zucker rats: Glomerular hemodynamic alterations and effects of enalapril, Am J Physiol, 263, F496 Anderson, 1988, Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome, J Clin Invest, 82, 1757, 10.1172/JCI113789 Amato, 1992, Mechanisms involved in the progression to glomerular sclerosis induced by systemic hypertension during mild puromycin aminonucleoside nephrosis, Am J Hypertens, 5, 629, 10.1093/ajh/5.9.629 Lafayette, 1992, Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass, J Clin Invest, 90, 766, 10.1172/JCI115949 Mackenzie, 1994, TCV116 prevents the progressive renal injury in rats with extensive renal mass ablation, J Hypertens, 12, S11 Fogo, 1997, Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) trial, Kidney Int, 51, 244, 10.1038/ki.1997.29 Weiss, 1939, Pyelonephritis: its relation to vascular lesions and to arterial hypertension, Medicine (Baltimore), 18, 221, 10.1097/00005792-193909000-00001 Gilbert, 1999, The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?, Kidney Int, 56, 1627, 10.1046/j.1523-1755.1999.00721.x Wang, 1999, Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappa B activation, J Am Soc Nephrol, 10, 1204, 10.1681/ASN.V1061204 Zoja, 1998, Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation, Kidney Int, 53, 1608, 10.1046/j.1523-1755.1998.00905.x Lynn, 2000, Very low-density lipoprotein stimulates the expression of monocyte chemoatttractant protein-1 in mesangial cells, Kidney Int, 57, 1472, 10.1046/j.1523-1755.2000.00992.x Ricardo, 1996, Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis, Kidney Int, 50, 2002, 10.1038/ki.1996.522 Klahr, 1998, The role of growth factors, cytokines and vasoactive compounds in obstructive nephropathy, Semin Nephrol, 18, 622 Morrisey, 1998, Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis, Am J Physiol, 274, F580 Shyy, 1994, Fluid shear stress induces a biphasic response of human monocyte chemotactic protein-1 gene expression in vascular endothelium, Proc Natl Acad Sci USA, 91, 4678, 10.1073/pnas.91.11.4678 Hsieh, 1991, Shear stress increases endothelial platelet-derived growth factor messenger RNA levels, Am J Physiol, 260, H642 Gimbrone, 1997, Hemodynamics, endothelial gene expression and atherogenesis, Ann NY Acad Sci, 811, 1, 10.1111/j.1749-6632.1997.tb51983.x Wampola, 1995, Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress, Arterioscler Thromb Vasc Biol, 15, 2, 10.1161/01.ATV.15.1.2 Ishida, 1997, Fluid shear stress-mediated signal transduction: How do endothelial cells transduce mechanical force into biological responses, Ann NY Acad Sci, 811, 12, 10.1111/j.1749-6632.1997.tb51984.x Dezso, 1989, Evidence for the presence of angiotensins in normal, unstimulated alveolar macrophages and monocytes, J Hypertens, 7, 5, 10.1097/00004872-198901000-00002 Weinstock, 1984, Granuloma macrophages in murine Schistosomiasis mansoni generate components of the angiotensin system, Cell Immunol, 89, 39, 10.1016/0008-8749(84)90195-3 Klahr, 2000, The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease, Kidney Int, 57, S7, 10.1046/j.1523-1755.2000.07509.x Rodr´guez-Iturbe, 1945, Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure, Kidney Int Quiroz, 1925, Mycophenolate mofetil prevents the salt-sensitive hypertension resulting from short-term nitric oxide synthesis inhibition. A role for immune cells and microvascular injury, Am J Physiol